हिंदी

Delhi HC Seeks Centre’s Stand on Challenge to Fixed Dose Combination Drug Ban

Delhi

The Delhi High Court has requested the Centre to present its position regarding a petition filed by a pharmaceutical company that challenges the government’s decision to ban the manufacture, sale, and distribution of certain Fixed Dose Combination (FDC) drugs for human use.

FDC drugs are those that contain a fixed ratio of two or more active pharmaceutical ingredients (APIs).

While issuing notices on three petitions filed by Glenmark Pharmaceuticals Ltd against the ban, the court has directed that the FDC drugs produced by the petitioners, which are already in the distribution channel, should not be withdrawn. It further ordered that no coercive measures be taken against the petitioners.

Recommended For You

About the Author: Meera Verma

Delhi HC Directs MCD, Police To Address Issues In Chandni Chowk Delhi HC Issues Notice On Shabir Shah’s Plea For Phone Access In Custody Judge Recommends Sending Terror Case Against Engineer Rashid To MP/MLA Court Bombay HC Imposes Rs.25,000 Cost On Nashik Prison Jailor Kerala HC Orders Probe Into Minister Cherian’s Remarks